Kathleen M. Ventre

TL;DR: The cumulative results of three small trials show that ribavirin may reduce the duration of mechanical ventilation and may reduce days of hospitalization, and use of ribvirin may be associated with a decrease in the long-term incidence of recurrent wheezing following RSV disease.

TL;DR: Surfactant seems to be a promising intervention, and corticosteroids or ribavirin may also be beneficial, and there are no clearly effective interventions available to improve the outcome of critically ill infants with bronchiolitis.

TL;DR: A multimodal discharge preparedness curriculum, incorporating high‐fidelity simulation training, to prepare family caregivers of children with complex medical conditions requiring long‐term mechanical ventilation and observed a trend toward reduced readmissions within 7 days of discharge since implementation of this revised curriculum.

TL;DR: Data in the neonatal population suggests significant benefits in pulmonary outcomes when HFOV is applied with a recruitment strategy in preterm infants with respiratory distress syndrome (RDS), but use in the paediatric and adult populations has not as yet been associated with significant improvements in clinically important outcome measures.

TL;DR: There have been important new developments relevant to the pathogenesis and management of pediatric respiratory diseases, and new insights into the causal pathways of respiratory syncytial virus-induced airways disease can potentially lead to novel therapies.